睿知中国疾病研究地图
候选清单0

正在招募胃癌不分期

登记标题,引自 ClinicalTrials.gov(英文原文,暂无中文译文)

Two-component Radiology-guided Autonomous Cascade Engine (TRACE)

ClinicalTrials.gov 上登记的一项胃癌开放试验,由辽宁省肿瘤医院牵头,本站收录的另外 0 家医院列为研究中心。

状态、分期和开始时间依据 ClinicalTrials.gov 在 2026年11月8日 的登记,登记库此后可能已有更新。能否参加由研究团队决定。不构成医疗建议。

研究团队的联系方式见登记记录。本站不转递咨询。

列出这项试验的中国大陆医院 1

登记记录中列为牵头方或研究中心、且为本站收录的医院(研究中心为开放状态)。牵头方在前,研究中心按英文名称字母排序。

  1. 牵头方辽宁省肿瘤医院Liaoning Cancer Hospital & Institute沈阳医院页面

登记记录可能还列有其他研究中心(包括中国大陆以外),各中心在试验期间也可能开放或关闭。在 ClinicalTrials.gov 查看全部研究中心

来源:ClinicalTrials.gov 登记记录 NCT07651644,读取于 2026年11月8日;医院名称与本站医院名单匹配。 名称如何匹配

这项试验的核对清单 1

只列这项试验的登记记录有明确答案的要点:登记的年龄和性别,以及写明数值、评分、分期或具体检查的标准条目。与医疗资料对照后可勾选。条目为英文原文,暂无中文译文。

展开清单(1 项)收起清单
  1. Patients with a definitive postoperative pathological diagnosis of gastric cancer and a clear T-stage classification (T1-T4, including T4a and T4b);

    入选标准第 2 条

    Complete clinical and pathological information must be available to establish a diagnostic gold standard for comparison.

    入选标准第 4 条

    Lack of clear postoperative pathological T-staging results;

    入选标准第 10 条

    Cases not involving gastric cancer or with incomplete pathological information;

    入选标准第 11 条

    Cases where critical data errors are identified during subsequent verification or where pathological results cannot be traced; Data found during the study to be non-compliant with ethical or quality control requirements must be excluded.

    入选标准第 18 条

勾选只留在本页面,不保存、不发送。各项都符合也不等于能够参加,由研究团队经筛查后决定。需要研究团队判断的条目(如 “sufficient organ function”)不在此清单中,见下方完整标准。 本记录没有明确写出:分期或严重程度(按试验的定义);既往治疗;日常活动能力;化验:血常规、肝肾功能;影像与可测量病灶;试验排除的其他疾病;怀孕、哺乳与避孕。

需要向研究团队确认的问题

按固定关键词规则从登记记录中选出(非 AI,未经人工核对),引自 ClinicalTrials.gov, NCT07651644,读取于 2026年11月10日。

登记的入选标准

依据 ClinicalTrials.gov 的登记,读取于 2026年11月10日,未删减。以下为英文原文,暂无中文译文。符合书面条件并不等于能够参加,由研究团队经筛查后决定。

入选标准:Inclusion Criteria:

  1. Contrast-enhanced CT (CE-CT) images of gastric cancer patients from the Liaoning Cancer Hospital;
  2. Patients with a definitive postoperative pathological diagnosis of gastric cancer and a clear T-stage classification (T1-T4, including T4a and T4b);
  3. Imaging data must be complete and of sufficient quality to meet diagnostic and analytical requirements, with no significant artefacts or missing key data;
  4. Complete clinical and pathological information must be available to establish a diagnostic gold standard for comparison.
  5. Radiologists holding a valid medical licence;
  6. From the radiology department of a Grade A tertiary hospital or a non-Grade A tertiary hospital;
  7. Classified as senior or junior physicians based on clinical experience;
  8. Voluntarily participating in this study and completing both the non-AI-assisted and AI-assisted image interpretation tasks.
  9. Severe missing imaging data or quality failing to meet analysis requirements (e.g., severe motion artefacts);
  10. Lack of clear postoperative pathological T-staging results;
  11. Cases not involving gastric cancer or with incomplete pathological information;
  12. Cases of duplicate enrolment or inconsistent data recording.
  13. Those unable to complete all image review tasks or demonstrating severe non-compliance;
  14. Those who withdraw during the study period and are unable to provide complete data for both phases of image review;
  15. Those who fail to complete the AI-assisted and non-AI-assisted interpretation processes as specified.
  16. Physicians who voluntarily withdraw from the study for personal reasons (e.g., time, health or work commitments);
  17. Physicians who fail to complete the required image review tasks or have data missing in excess of the specified threshold;
  18. Cases where critical data errors are identified during subsequent verification or where pathological results cannot be traced; Data found during the study to be non-compliant with ethical or quality control requirements must be excluded.

排除标准:Exclusion Criteria:

    引自 ClinicalTrials.gov, NCT07651644, 参与标准,读取于 2026年11月10日。

    这些信息从哪里来

    登记记录

    ClinicalTrials.gov(美国国家医学图书馆),登记记录 NCT07651644,读取于 2026年11月8日。总体状态为正在招募、即将招募或邀请入组、且至少有一家列出医院的研究中心开放的试验,在本站有单独页面。仅在中国临床试验注册中心(ChiCTR)登记的试验没有计入。

    疾病与医院

    本站在 ClinicalTrials.gov 按疾病检索中国的试验,检索到这项试验,就把它列在该病下。登记记录中的牵头方和研究中心名称与本站医院名单匹配(ROR 编号与核对过的别名)。 定义

    没有收录的内容

    登记记录中研究者和联系人的姓名,以及记录之外的任何信息。标题和入选标准引自登记记录。

    提出更正ClinicalTrials.gov NCT07651644